-
-
Call more information
660-596-2224 -
Anesthesia & Analgesia: February 2016 – Volume 122 – Issue 2 – p 321–329 AUTHORS: Cobey, Frederick C. MD, MPH, FASE et al BACKGROUND: In patients with mitral regurgitation (MR), the effective regurgitant orifice area can be estimated by measuring the vena contracta area (VCA). We hypothesize that the VCA has characteristic temporal dynamics related […]
Read MoreAnesthesia & Analgesia: February 2016 – Volume 122 – Issue 2 – p 482–489 AUTHORS: Zgleszewski, Steven E. MD et al BACKGROUND: Pediatric anesthesia-related cardiac arrest (ARCA) is an uncommon but potentially preventable adverse event. Infants and children with more severe underlying disease are at highest risk. We aimed to identify system- and anesthesiologist-related risk […]
Read MoreAnesthesia & Analgesia: February 2016 – Volume 122 – Issue 2 – p 490–496 AUTHORS: Hörner, Elisabeth MD et al BACKGROUND: The immediate initiation and high quality of basic life support (BLS) are pivotal to improving patient outcome after cardiac arrest. Although cardiorespiratory monitoring could shorten the time to recognize the onset of cardiac arrest, […]
Read MoreAnesthesia & Analgesia: February 2016 – Volume 122 – Issue 2 – p 503–508 AUTHORS: Mebel, Dmitry MD et al BACKGROUND: Compared with other procedures, complex skull base neurosurgery has the potential for increased intraoperative blood loss yet coagulation near eloquent cranial structures should be minimized. The safety and efficacy of the antifibrinolytic, tranexamic acid […]
Read MoreAnesthesia & Analgesia: February 2016 – Volume 122 – Issue 2 – p 449–453 AUTHORS: Lu, Zhen MPH et al BACKGROUND: Malignant hyperthermia (MH) is a rare yet potentially fatal pharmacogenetic disorder triggered by exposure to inhaled anesthetics and the depolarizing neuromuscular blocking drug succinylcholine. Epidemiologic research on MH is largely limited to inpatients. In […]
Read More